These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18550483)

  • 1. Effects of hemoglobin C and S traits on the results of 14 commercial glycated hemoglobin assays.
    Mongia SK; Little RR; Rohlfing CL; Hanson S; Roberts RF; Owen WE; D'Costa MA; Reyes CA; Luzzi VI; Roberts WL
    Am J Clin Pathol; 2008 Jul; 130(1):136-40. PubMed ID: 18550483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hemoglobin C and S traits on Tosoh G8 and Siemens Advia HbA1c assays.
    Little RR; Rohlfing CL; Hanson SE; Roberts WL
    Clin Chim Acta; 2010 May; 411(9-10):779-80. PubMed ID: 20171960
    [No Abstract]   [Full Text] [Related]  

  • 3. Performance of the Roche second generation hemoglobin A1c immunoassay in the presence of HB-S or HB-C traits.
    Abadie JM; Koelsch AA
    Ann Clin Lab Sci; 2008; 38(1):31-6. PubMed ID: 18316779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods.
    Little RR; Rohlfing CL; Hanson S; Connolly S; Higgins T; Weykamp CW; D'Costa M; Luzzi V; Owen WE; Roberts WL
    Clin Chem; 2008 Aug; 54(8):1277-82. PubMed ID: 18556332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin S monitoring on TOSOH G8 in hemoglobin A1c mode in case of urgent red blood cell exchange.
    Van Aelst S; Claerhout H; Nackers E; Desmet K; Kieffer D
    J Clin Lab Anal; 2018 Sep; 32(7):e22453. PubMed ID: 29667731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of variant hemoglobins interfering with hemoglobin A1c measurement.
    Little RR; Roberts WL
    J Diabetes Sci Technol; 2009 May; 3(3):446-51. PubMed ID: 20144281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hemoglobin C, D, E and S traits on measurements of hemoglobin A1c by twelve methods.
    Rohlfing C; Hanson S; Weykamp C; Siebelder C; Higgins T; Molinaro R; Yip PM; Little RR
    Clin Chim Acta; 2016 Apr; 455():80-3. PubMed ID: 26828530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantage of HbA1c assay by HPLC D-10 versus cobas integra 400 in a population carrier for HbS and HbC.
    Bouzid K; Bahlous A; Ferjani W; Kalai E; Ducrocq R; Ben Mami F; Abdelmoula J
    Clin Lab; 2012; 58(7-8):821-8. PubMed ID: 22997985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in HbA1c analysis and reporting: an interesting case illustrating the many pitfalls.
    Higgins T; Stewart D; Boehr E
    Clin Biochem; 2008 Sep; 41(13):1104-6. PubMed ID: 18602911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sickle cell trait and hemoglobin C trait on determinations of HbA1c by an immunoassay method.
    Roberts WL; McCraw M; Cook CB
    Diabetes Care; 1998 Jun; 21(6):983-6. PubMed ID: 9614618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the Afinion HbA1c Point-of-Care instrument be an alternative method for the Tosoh G8 in the case of Hb-Tacoma?
    Lenters-Westra E; Strunk A; Campbell P; Slingerland RJ
    Scand J Clin Lab Invest; 2017 Feb; 77(1):2-7. PubMed ID: 27191339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of glycated hemoglobin in clinically silent hemoglobin variants.
    Schnedl WJ; Lahousen T; Lang T; Lipp RW; Yonehara S; Fukunaga S; Imai T; Little RR
    Diabetes Metab Res Rev; 2004; 20(6):460-5. PubMed ID: 15386816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology consultation on HbA(1c) methods and interferences.
    Rhea JM; Molinaro R
    Am J Clin Pathol; 2014 Jan; 141(1):5-16. PubMed ID: 24343732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of hemoglobin J-Bangkok traits on measurements of glycated hemoglobin by five methods].
    Wen DM; Zhang XM; Suo MH; Xu SN; Zhang DC; Chen YQ
    Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(2):113-7. PubMed ID: 26792693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher degree of glycation of hemoglobin S compared to hemoglobin A measured by mass spectrometry: Potential impact on HbA1c testing.
    Kabytaev K; Connolly S; Rohlfing CL; Sacks DB; Stoyanov AV; Little RR
    Clin Chim Acta; 2016 Jul; 458():40-3. PubMed ID: 27112303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance evaluation of ion exchange and affinity chromatography for HbA1c estimation in diabetic patients with HbD: a study of 129 samples.
    Moiz B; Hashmi MR; Sadaf S
    Clin Biochem; 2008 Oct; 41(14-15):1204-10. PubMed ID: 18644359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin.
    Bry L; Chen PC; Sacks DB
    Clin Chem; 2001 Feb; 47(2):153-63. PubMed ID: 11159762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sickle cell trait and B-Thalassemia minor on determinations of HbA1c by an immunoassay method.
    Al-Fadhli SM; Ahmad AA; Al-Jafar HA
    Saudi Med J; 2001 Aug; 22(8):686-9. PubMed ID: 11573113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perioperative monitoring of hemoglobin fractions in homozygous sickle cell disease].
    Frietsch T; Segiet W; Schütz P; Haux P; Lorentz A
    Anaesthesist; 1999 Apr; 48(4):231-5. PubMed ID: 10352787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. False measurement of glycated hemoglobin in patients without hemoglobin A.
    Suo M; Wen D; Wang W; Zhang D; Xu S; Wang X; Hu T
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 29720428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.